Johnson & Johnson (JNJ) Stock Research, Analysis & News

Quick Analysis on Johnson & Johnson (JNJ) Stock as of October 20, 2017

Previous Closing Price $142.04 is above 50 day moving average of $133.48
Previous Closing Price $142.04 is above 200 day moving average of $130.63
The Price/Earnings To Growth ratio (PEG) is great than 1
The Stock pays a dividend of 2.39%
The closing price $142.04 is less than 1.65% away from its one year target price of $144.38
Current Short Ratio 2.41 is great than 1
(See more information about Johnson & Johnson (JNJ) Stock below)

Johnson & Johnson (JNJ) Stock Profile Summary

Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment provides products used in baby care, skin care, oral care, wound care, and womens health care fields, as well as nutritional, over-the-counter pharmaceutical products, and wellness and prevention platforms under the names JOHNSONS, AVEENO, CLEAN & CLEAR, JOHNSONS Adult, NEUTROGENA, RoC, LUBRIDERM, Dabao, Vendome, LISTERINE, REACH, BAND-AID, PURELL, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC. The Pharmaceutical segment offers products in various therapeutic areas, such as anti-infective, antipsychotic, cardiovascular, contraceptive, dermatology, gastrointestinal, immunology, neurology, oncology, urology, and virology. Its products include REMICADE, a biologic approved for the treatment of immune mediated inflammatory diseases; PROCRIT, a biotechnology-derived product that stimulates red blood cell production; LEVAQUIN, which is used in the anti-infective field; RISPERDAL CONSTA, a injectable for the treatment of schizophrenia; CONCERTA, a product for the treatment of attention deficit hyperactivity disorder; ACIPHEX/PARIET, a proton pump inhibitor; DURAGESIC/Fentanyl Transdermal, a treatment for chronic pain; VELCADE for the treatment of multiple myeloma; PREZISTA for treating HIV/AIDS patients; and INVEGA, a atypical antipsychotic. The Medical Devices and Diagnostics segment primarily offers circulatory disease management products; orthopaedic joint reconstruction, spinal care, and sports medicine products; surgical care, aesthetics, and womens health products; blood glucose monitoring and insulin delivery products; professional diagnostic products; and disposable contact lenses. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Johnson & Johnson (JNJ) Stock Key Statistics Research and Analysis as of October 20, 2017

Stock ExchangeNYQ
Market Capitalization$382.55B
Trade Volume (Average Trading Volume)2,900,019 (5,358,020)
Price/Sales5.13
Price/Book5.30
P/E24.79
Earning/Share$5.75
Current Year EPS Estimate$7.27
Next Year EPS Estimate$7.84
Previous Closing Price$142.04
50 Day Price Moving Average$133.48
200 Day Price Moving Average$130.63
Dividend Yield2.39%
1 yr Target Price$144.38
Ex-Dividend Date8/25/2017
PEG Ratio2.80
Short Ratio2.41
EBITDA$25.02B

Johnson & Johnson (JNJ) Stock Competitor Research and Analysis

Abbott Laboratories (ABT)Eli Lilly & Co. (LLY)
Novartis AG (NVS)Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)Life Technologies Corporation (LIFE)
Teva Pharmaceutical Industries Limited (TEVA)Watson Pharmaceuticals Inc. (WPI)
King Pharmaceuticals Inc. (KG)Mylan, Inc. (MYL)
Pfizer Inc. (PFE)GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)

Mutual Funds with Johnson & Johnson (JNJ) Stock in its top 10 holdings

FundCategoryJNJ Holding Percentage
Alpine Accelerating Dividend InstlLarge Blend2.82%
ASTON/Cornerstone Large Cap Value ILarge Value4.93%
American Century Value BLarge Value1.87%
American Century Capital Val ALarge Value2.43%
Invesco ExchangeLarge Blend5.15%
American Century Income & Growth CLarge Value2.45%
American Century Legacy Multi Cap RMid-Cap Blend1.32%

ETFs with Johnson & Johnson (JNJ) Stock in its top 10 holdings

Stock Research on Johnson & Johnson (JNJ)

Latest Market News on Johnson & Johnson (JNJ)


Click here to find the latest news on Johnson & Johnson (JNJ)

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Abbott Laboratories (ABT)
Eli Lilly & Co. (LLY)
Novartis AG (NVS)
Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)
Life Technologies Corporation (LIFE)
Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)
King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)
Pfizer Inc. (PFE)
GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)